154 related articles for article (PubMed ID: 36970202)
1. Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection.
Wu LL; Zhao Q; Wang Q; Zhang Q; Yang F; Zheng B; Hu HY; Xing N
Acta Pharm Sin B; 2023 Mar; 13(3):1204-1215. PubMed ID: 36970202
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.
Kularatne SA; Thomas M; Myers CH; Gagare P; Kanduluru AK; Crian CJ; Cichocki BN
Clin Cancer Res; 2019 Jan; 25(1):177-187. PubMed ID: 30201762
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
[TBL] [Abstract][Full Text] [Related]
5. PSMA-targeted NIR probes for image-guided detection of prostate cancer.
Cilibrizzi A; Wang JT; Memdouh S; Iacovone A; McElroy K; Jaffar N; Young JD; Hider RC; Blower P; Al-Jamal K; Abbate V
Colloids Surf B Biointerfaces; 2022 Oct; 218():112734. PubMed ID: 35952398
[TBL] [Abstract][Full Text] [Related]
6.
Yılmaz B; Şahin S; Ergül N; Çolakoğlu Y; Baytekin HF; Sökmen D; Tuğcu V; Taşçı Aİ; Çermik TF
Ann Nucl Med; 2022 Jul; 36(7):597-609. PubMed ID: 35426599
[TBL] [Abstract][Full Text] [Related]
7. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
[TBL] [Abstract][Full Text] [Related]
8. A targeted near-infrared nanoprobe for deep-tissue penetration and imaging of prostate cancer.
Asha Krishnan M; Yadav K; Roach P; Chelvam V
Biomater Sci; 2021 Mar; 9(6):2295-2312. PubMed ID: 33554988
[TBL] [Abstract][Full Text] [Related]
9. A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation.
Capozza M; Stefania R; Dinatale V; Bitonto V; Conti L; Grange C; Skovronova R; Terreno E
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361667
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes.
Teh J; Tripathi M; Reichel D; Sagong B; Montoya R; Zhang Y; Wagner S; Saouaf R; Chung LWK; Perez JM
Nanotheranostics; 2021; 5(1):57-72. PubMed ID: 33391975
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.
Sengupta S; Asha Krishnan M; Chattopadhyay S; Chelvam V
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1169. PubMed ID: 32721116
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and
Cordonnier A; Boyer D; Besse S; Valleix R; Mahiou R; Quintana M; Briat A; Benbakkar M; Penault-Llorca F; Maisonial-Besset A; Maunit B; Tarrit S; Vivier M; Witkowski T; Mazuel L; Degoul F; Miot-Noirault E; Chezal JM
J Mater Chem B; 2021 Sep; 9(36):7423-7434. PubMed ID: 34373887
[TBL] [Abstract][Full Text] [Related]
13. Value of
Rauscher I; Düwel C; Wirtz M; Schottelius M; Wester HJ; Schwamborn K; Haller B; Schwaiger M; Gschwend JE; Eiber M; Maurer T
BJU Int; 2017 Jul; 120(1):40-47. PubMed ID: 27862863
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
[No Abstract] [Full Text] [Related]
15. The Value of
Su HC; Zhu Y; Hu SL; Liu C; Lin GW; Dai B; Zhang YJ; Ye DW
Ann Surg Oncol; 2019 Feb; 26(2):653-659. PubMed ID: 30324468
[TBL] [Abstract][Full Text] [Related]
16. PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery.
Derks YHW; Löwik DWPM; Sedelaar JPM; Gotthardt M; Boerman OC; Rijpkema M; Lütje S; Heskamp S
Theranostics; 2019; 9(23):6824-6839. PubMed ID: 31660071
[TBL] [Abstract][Full Text] [Related]
17. Primary lymph-node staging with
Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
[TBL] [Abstract][Full Text] [Related]
18. Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy.
Budäus L; Leyh-Bannurah SR; Salomon G; Michl U; Heinzer H; Huland H; Graefen M; Steuber T; Rosenbaum C
Eur Urol; 2016 Mar; 69(3):393-6. PubMed ID: 26116958
[TBL] [Abstract][Full Text] [Related]
19. Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer.
de Korne CM; Wit EM; de Jong J; Valdés Olmos RA; Buckle T; van Leeuwen FWB; van der Poel HG
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2558-2568. PubMed ID: 31377820
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]